Actively Recruiting

Age: 18Years +
All Genders
NCT05080998

Longitudinal Bladder Cancer Study for Tumour Recurrence

Led by Pacific Edge Limited · Updated on 2025-11-10

450

Participants Needed

7

Research Sites

220 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Surveillance for recurrence of urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the potential to reduce the number of cystoscopies required during post-treatment surveillance. This is a prospective, single arm, multi-center study using the diagnostic CxBladder test with subjects previously diagnosed with primary or recurrent UC and who are undergoing a schedule of investigative cystoscopies and treatment for the possible recurrence of UC presenting to qualified sites. To evaluate the performance characteristics of the CxBladder test, multiple consecutive urine samples will be collected during the course of surveillance.

CONDITIONS

Official Title

Longitudinal Bladder Cancer Study for Tumour Recurrence

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Low-, intermediate-, and high-risk patients previously diagnosed with urothelial carcinoma within the last 3 years
  • Agree to attend 4 successive study visits with urine sample collection
  • Physically able to provide a voided urine sample (not catheterized)
  • Able to give written informed consent
  • Willing and able to comply with study requirements
  • Aged 18 years or older
Not Eligible

You will not qualify if you...

  • Patients who have had total bladder removal, neo-bladder, or ileal conduit
  • History of muscle invasive bladder tumor (pT2 or greater)
  • Known pregnancy
  • Recent genitourinary procedures within 14 days before urine collection
  • Active urinary tract infection within 14 days before urine collection
  • Intravesical immunotherapy or chemotherapy within the previous 6 weeks

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Miami VA Healthcare System

Miami, Florida, United States, 33125

Actively Recruiting

2

James A. Haley Veteran's Hospital

Tampa, Florida, United States, 33612

Actively Recruiting

3

Ralph H. Johnson VA Health Care System

Charleston, South Carolina, United States, 29401

Actively Recruiting

4

UT Southwestern Medical Center

Dallas, Texas, United States, 75390

Actively Recruiting

5

White River Junction Veterans Affair Medical Center

White River Junction, Vermont, United States, 05009

Actively Recruiting

6

University of Washington School of Medicine

Seattle, Washington, United States, 98195

Actively Recruiting

7

Monash Health - Moorabbin Hospital

Clayton, Victoria, Australia, 3165

Actively Recruiting

Loading map...

Research Team

D

Donna Smith, MSc (Hons)

CONTACT

A

Alexis White

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here